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Abstract
Background. The increased use of the MATRICS Consensus Cognitive Battery (MCCB) to
investigate cognitive dysfunctions in schizophrenia fostered interest in its sensitivity in the
context of family studies. As various measures of the same cognitive domains may have dif-
ferent power to distinguish between unaffected relatives of patients and controls, the relative
sensitivity of MCCB tests for relative–control differences has to be established. We compared
MCCB scores of 852 outpatients with schizophrenia (SCZ) with those of 342 unaffected rela-
tives (REL) and a normative Italian sample of 774 healthy subjects (HCS). We examined
familial aggregation of cognitive impairment by investigating within-family prediction of
MCCB scores based on probands’ scores.
Methods. Multivariate analysis of variance was used to analyze group differences in adjusted
MCCB scores. Weighted least-squares analysis was used to investigate whether probands’
MCCB scores predicted REL neurocognitive performance.
Results. SCZ were significantly impaired on all MCCB domains. REL had intermediate scores
between SCZ and HCS, showing a similar pattern of impairment, except for social cognition.
Proband’s scores significantly predicted REL MCCB scores on all domains except for visual
learning.
Conclusions. In a large sample of stable patients with schizophrenia, living in the community,
and in their unaffected relatives, MCCB demonstrated sensitivity to cognitive deficits in both
groups. Our findings of significant within-family prediction of MCCB scores might reflect dis-
ease-related genetic or environmental factors.
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Introduction
Cognitive deficits represent core features of schizophrenia, observ-
able in all stages of the disorder and before its onset, irrespective
of the severity of symptoms (Heinrichs & Zakzanis, 1998; Green
et al. 2000, 2004; Galderisi et al. 2002, 2009, 2013; Keefe et al.
2011; Kern et al. 2011; Bora et al. 2014; Dickerson et al. 2014).
They are strong predictors of functional outcome (Green et al.
2000; Bowie et al. 2006; Harvey & Strassnig, 2012; Galderisi
et al. 2014) and have a greater impact on social functioning
than positive and negative symptoms (Leifker et al. 2009; Kurtz
et al. 2010; Harvey & Strassnig, 2012; Galderisi et al. 2014, 2016).
Deficits in social cognition (i.e. emotion processing and man-
agement, theory of mind, social perception and attributional style)
(Green et al. 2008) were reported in all phases of the disorder and
in the prodromal period (Kohler et al. 2010; Fett et al. 2011;
Green et al. 2012a; Gallagher & Varga, 2015; Green, 2016).
These deficits are only partly predicted by other cognitive deficits,
and were found to mediate the impact of the latter on functional
outcome and to explain a unique proportion of functional out-
come variance (Couture et al. 2011; Fett et al. 2011; Mancuso
et al. 2011; Schmidt et al. 2011; Green et al. 2012b; Galderisi
et al. 2014; Green, 2016).
The Measurement and Treatment Research to Improve
Cognition in Schizophrenia (MATRICS) Consensus Cognitive
Battery (MCCB, Kern et al. 2008; Nuechterlein et al. 2008) was
developed to provide a comprehensive assessment of cognitive
functioning in patients with schizophrenia or schizoaffective dis-
order for the purposes of conducting clinical trials (Nuechterlein
et al. 2008). Previous findings showed that the MCCB is a sensi-
tive instrument to detect cognitive impairments in patients with
schizophrenia (Keefe et al. 2011; Kern et al. 2011; Shamsi et al.
2011; Lystad et al. 2014; McCleery et al. 2014) and changes fol-
lowing either pharmacological or cognitive remediation interven-
tions (for a review, see Green et al. 2014).
Cognitive dysfunction has also been found in non-psychotic
first-degree relatives of schizophrenia patients, with a severity of
impairment intermediate between patients and controls
(Brahmbhatt et al. 2006; Snitz et al. 2006; Gur et al. 2007; Chen
et al. 2009; de Achával et al. 2010; Bora & Pantelis, 2013), suggest-
ing that cognitive dysfunction can potentially be used as a marker
of genetic vulnerability for psychosis (Grove et al. 1991; Chen
et al. 1998; Sitskoorn et al. 2004; Gur et al. 2007; Calkins et al.
2010, 2013; Seidman et al. 2015). Attention, verbal memory,
and executive control were generally found more impaired than
other functions (Sitskoorn et al. 2004; Snitz et al. 2006; Gur
et al. 2007; Seidman et al. 2015), but effects were influenced by
the included tests or measures and by a number of other factors,
such as the type of relationship with the proband (parent/sibling/
offspring), matching between relatives and controls, and the pres-
ence of an axis I (other than schizophrenia) or II diagnosis in
relatives (Snitz et al. 2006; Gur et al. 2007; Calkins et al. 2013;
Gur & Gur, 2016). Social cognition deficits were also found in
relatives of patients with schizophrenia, although with some
inconsistency in the literature as to what specific deficit is involved
(Fett et al. 2011; Bora & Pantelis, 2013; Lavoie et al. 2013).
TheMCCB includes some of the tests andmeasures consistently
found to differ between relatives and controls (Gur et al. 2007;
Calkins et al. 2013; Seidman et al. 2015), but also other measures
for which the sensitivity to impairment in unaffected relatives
and the pattern of aggregation in families remain unexplored.
To our knowledge, only one study reported relatives–controls
differences on MCCB tests (Lopez-Garcia et al. 2013), including
<50 unaffected relatives.
The first aim of the present study was to investigate cognitive
impairment of a large sample of outpatients with schizophrenia
and their unaffected first-degree relatives, recruited for the
Italian Network for Research on Psychoses study (Galderisi
et al. 2014, 2016). The normative sample for the standardization
of the MCCB battery is representative of the Italian population
and has been recruited in the same study. The second aim of
the study was to explore familial aggregation of performance on
MCCB domains by estimating probands’ effects on MCCB scores
of unaffected relatives.
Methods
Subjects
Study participants were patients, unaffected relatives, and healthy
controls recruited for the Italian Network for Research on
Psychosis study (Galderisi et al. 2014, 2016).
Specifically, 921 patients living in the community and con-
secutively seen at the outpatient units of 26 Italian university psy-
chiatric clinics and/or mental health departments were enrolled if
they had a diagnosis of schizophrenia confirmed with the
Structured Clinical Interview for DSM-IV – Patient version
(SCID-I-P) and an age between 18 and 66 years. Exclusion criteria
were: (a) a history of head trauma with loss of consciousness; (b) a
history of moderate-to-severe mental retardation or of neuro-
logical diseases; (c) a history of alcohol and/or substance abuse
in the last 6 months; (d) current pregnancy or lactation; (e) inabil-
ity to provide an informed consent; and (f) any antipsychotic
treatment modifications and/or hospitalization due to symptom
exacerbation in the last 3 months. The 26 study sites were grouped
into three macro-areas: Northern Italy (eight centers), Southern
Italy (seven centers, including the isles Sicily and Sardinia) and
Central Italy (11 centers). Of the 921 recruited patients, 852
had complete demographic and neuropsychological data and
were used in the present analyses.
For each recruited patient who agreed to involve relatives, two
first-degree relatives were recruited, when available. They had to
be, in order of preference, the two parents, or one parent and
one sibling, or two siblings. Relatives were asked to participate
and included in the study if they did not meet criteria for a cur-
rent or lifetime psychiatric diagnosis as assessed by the
SCID-I-Non Patient version and the SCID-II. Further exclusion
criteria were: (a) a history of head trauma with loss of conscious-
ness, (b) neurological disease, (c) history of alcoholism or sub-
stance abuse in the last 6 months, and (d) inability to provide
informed consent.
According to the above criteria, 379 unaffected relatives (REL)
were recruited. About two-thirds were parents and one-third sib-
lings (they included 109 fathers, 150 mothers, 67 sisters, and 53
brothers). Three hundred and forty-two relatives had complete
data and were utilized in the analyses. They were related to 247
probands (29.9% of the total proband sample used in the present
analyses). One hundred twenty-five probands had one relative,
122 had two relatives.
Healthy subjects were recruited through flyers from the com-
munity at the same sites as the patient sample, using a stratified
design by age, gender, and education within geographical macro-
areas. They were included if: (1) they had a negative family history
of mood or psychotic disorders; (2) they did not meet criteria for
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a current or lifetime psychiatric diagnosis as assessed by the
SCID-I-Non Patient version and the SCID-II, as well as other
exclusion criteria listed for the relatives.
Each macro-area had to contribute at least 200 control subjects
(maximum 333). As to age, controls were drawn from three groups:
18–39, 40–49, and 50–59 years. Because age-related changes in cog-
nition are typically small for persons in their 20s and 30s (Kern
et al. 2008), these two decades were treated as a single age group.
As to education, controls were stratified according to three groups:
less than a high school degree, high school degree but less than a
bachelor’s degree, and a bachelor’s degree or higher.
According to the above criteria, 780 subjects were recruited.
Two hundred and seventy-eight were from Northern Italy, 241
from Southern Italy, and 261 from Central Italy. Females were
402 (51.5%) and males were 378 (48.5%); N = 323 (41.4%) were
aged 20–39 years, N = 213 (27.3%) 40–49 years, and N = 244
(31.3%) 50–59 years. Concerning education, 279 (35.8%) had
less than a high school degree, 340 (43.6%) had a high school
degree but less than a college degree, and 161 (20.6%) had at
least a bachelor’s degree. In the present analyses, only subjects
with complete demographic and neuropsychological data were
utilized (N = 774).
Procedures
All subjects provided written informed consent to participate after
receiving a comprehensive explanation of the study procedures
and goals.
The study has been conducted in accordance with the princi-
ples of the Declaration of Helsinki (59th World Medical
Association General Assembly; October 2008). Approval of the
study protocol was obtained from the Ethics Committees of the
participating centers.
Assessments
Enrolled subjects completed the relevant assessments for the
study in 2 days with the following schedule: collection of socio-
demographic information and diagnostic interviews on day 1, in
the morning; assessment of cognition on day 2, in the morning,
to control for time-of-day effects on cognitive performance. The
full study procedure has been reported elsewhere (Galderisi
et al. 2014, 2016).
Neurocognitive functions were evaluated using the MCCB
(Kern et al. 2008; Nuechterlein et al. 2008). Briefly, the MCCB
includes 10 neuropsychological tests (Category Fluency – Animal
Naming; Brief Assessment of Cognition in Schizophrenia Symbol
Coding; Trail Making Test – Part A; Continuous Performance
Test – Identical Pairs; Wechsler Memory Scale Spatial Span;
Letter-Number Span; Hopkins Verbal Learning Test – Revised;
Brief Visuospatial Memory Test – Revised; Neuropsychological
Assessment Battery – Mazes; Mayer-Salovey-Caruso Emotional
Intelligence Test), and investigates seven cognitive domains
(Speed of processing; Attention/vigilance; Working memory;
Verbal learning; Visual learning; Reasoning and problem solving;
and Social cognition). The 10 MCCB tests were administered in
the order established by Kern et al. (2008).
Data analysis
Co-norming and standardization of the Italian MCCB test scores
was carried out as described in Kern et al. (2008). Raw scores on
the MCCB were standardized to T-scores based on the Italian
normative sample of community participants.
For cognitive domains including more than one measure, that
is, Working memory and Speed of processing, the summary score
for the domain was calculated by summing the T-scores of the
tests included in that domain and then standardizing the sum
to a T-score. The same standardization procedure was adopted
for the Neurocognitive and Overall composite scores: the six
(for neurocognitive) or seven (for overall composite) domain
T-scores were summed, and the composite score was calculated
by standardizing the sum to a T-score based on the community
sample.
In this way, all test scores, domain scores, and the composite
scores were standardized to the same measurement scale with a
mean of 50 and S.D. of 10.
The relationship between unadjusted cognitive T-scores and
demographic characteristics (gender, age, and education) in the
normative sample was analyzed using multivariate analysis of
variance (MANOVA).
MCCB domains T-scores adjusted for age, gender, and
education were compared between the study groups using
MANOVA.
Two analyses of variance (ANOVAs) were conducted to com-
pare the Neurocognitive composite and the Overall composite
corrected T-scores between groups. Post hoc Tamhane tests were
conducted following significant MANOVA and ANOVA F-tests
at the corrected significance level of p < 0.017 (0.05/3).
Weighted least-square regression models were used to predict
relatives’ unadjusted cognitive T-scores from probands’ T-scores.
Models were fit for each cognitive scale, the two domains includ-
ing more than a single test (Processing speed and Working mem-
ory) and for the two composite scores. These analyses were
weighted for the number of family members of the proband
and were adjusted for relatives’ gender, age, and relationship
with the patient (parent/sibling).
All analyses were performed using IBM SPSS, version 20.0.
Results
Demographic correlates of cognitive functioning in the
normative Italian sample
Uncorrected T-scores for the seven cognitive domains were sig-
nificantly associated with age, education, and gender in the nor-
mative sample (see online Supplementary Figs S1–S3). As
expected, neurocognitive performance declined significantly
with age on all domains. Social cognition had a decline from
the youngest age group (20–39) to the middle one, and then
did not show further decline (see online Supplementary
Fig. S1). The higher the education level, the better the perform-
ance across the three education groups for all neurocognitive
domains, while Social cognition was significantly better for the
two high-education groups v. the lowest one. Males performed
better than females on Attention/vigilance, Working memory,
Reasoning and problem solving, and the Neurocognitive compos-
ite, while females outperformed males on the Social cognition test
(see online Supplementary Fig. S3).
Cognitive profile of patients and relatives
Participant characteristics and summary T-scores corrected for
age, gender, and education for the MCCB tests are shown in
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Table 1 (participants with complete data only). Patients scored 1–
2 S.D. below the normative sample, and relatives scored about 0.5
S.D. below the normative sample. The MANOVA showed a signifi-
cant group effect (F = 87.4, df = 12,3974, p < 0.01). Post hoc pair-
wise comparisons showed that patients and relatives differed from
controls and from each other on all domains, while on Social cog-
nition patients differed from the two other groups, but relatives
did not differ from controls (Fig. 1). ANOVAs for the
Neurocognitive and the Overall composite showed a large effect
of group (F = 798.4, df = 2,1963, p < 0.001; F = 812.3, df = 2,1963,
p < 0.001). All post hoc comparisons were significant at p < 0.017
(Fig. 1).
Family aggregation of cognitive deficits as assessed by the
MCCB
Table 2 shows the results of weighted least-square regression
models for the MCCB tests/domains and composite scores. In
the unadjusted models, including only the proband score as the
independent variable, all proband scores predicted significantly
the relatives’ scores, except for Visual learning and Working
memory. However, after adjusting for relatives’ gender, age, and
relationship with the proband (parent/sibling), all relatives’ scores
were predicted by probands’ scores, except for visual learning.
Verbal learning scores had the strongest association between
patients and relatives (adj β = 0.237), followed by MSCEIT (adj
β = 0.230), Speed of processing (adj β = 0.208), Reasoning and
problem solving (adj β = 0.196), Working memory (adj β =
0.159) and Attention/vigilance (adj β = 0.116). For those models
showing a significant effect of proband scores, the variance
explained in the relative scores was relatively modest, and ranged
from 0.2% for Attention/vigilance to 5.8% for MSCEIT. The rela-
tive Overall and Neurocognitive composite scores were also sig-
nificantly associated with proband scores (adj β = 0.224 and
0.187, respectively; variance explained =4.6% and 3.3%,
respectively).
Discussion
In line with previous investigations, data from this standardization
sample demonstrated significant age, gender, and education
effects on the MCCB domains (Kern et al. 2008; Mohn et al.
2012; Rodriguez-Jimenez et al. 2015). As expected, age had a lin-
ear detrimental effect on cognitive performance for all domains,
with older age groups performing worse than younger ones,
except for the Social cognition domain, for which the two oldest
groups did not differ. Education showed a positive effect on the
MCCB scores of healthy adults, with better performance asso-
ciated with higher education. The gender effects observed in
our standardization sample confirmed those found in the original
study by Kern et al. (2008), showing that males had a better per-
formance than females on all domains except on learning. Our
findings demonstrated that females outperformed males on
Social cognition. These latter findings are in general agreement
with results obtained with MCCB (Mohn et al. 2012) and with
other test batteries in healthy subjects (Roalf et al. 2014; Gur &
Gur, 2016).
Using the Italian version of the MCCB, we confirmed the pro-
file of cognitive impairment reported by several independent
groups in a large cohort of stabilized chronic outpatients with
schizophrenia (Kern et al. 2008, 2011; Keefe et al. 2011; Shamsi
et al. 2011; Lystad et al. 2014; McCleery et al. 2014;
Rodriguez-Jimenez et al. 2015): on average, patients scored 1–2
S.D. below controls on all domains and on the composite scores.
In our study, unaffected relatives had intermediate scores with
respect to patients and controls on the MCCB neurocognitive
domains. Thus, in line with a previous small study
(Lopez-Garcia et al. 2013), our findings demonstrate that the
MCCB is suitable to explore impairment in non-psychotic rela-
tives of patients with schizophrenia. Our findings, in line with
other recent evidence (Schulze-Rauschenbach et al. 2015;
Hochberger et al. 2016), support the presence of deficits across
multiple domains in unaffected first-degree relatives of patients
with schizophrenia.
Table 1. Demographic characteristics and MCCB scores in the study groups
Group
Healthy
controls
(N = 774)
Unaffected
relatives (N =
342)
Patients with
schizophrenia (N
= 852)
N (%) N (%) N (%)
Gender
Females 400
(51.7%)
197 (57.6%) 258 (30.3%)
Males 374
(48.3%)
145 (42.4%) 594 (69.7%)
Mean ± S.D. Mean ± S.D. Mean ± S.D.
Age (years) 40.5 ± 12.5 53.9 ± 13.5 39.8 ± 10.6
Education
(years)
13 ± 4 11.5 ± 3.9 11.8 ± 3.4
MCCB
scores
TMT 50.1 ± 9.8 46.2 ± 11.6 35.5 ± 12.4
BACS-SC 50.1 ± 10.0 47.0 ± 8.4 36.3 ± 8.4
HVLT-R 50 ± 9.9 48.0 ± 11.2 35.6 ± 11.7
WMS-III
SS
50 ± 10 47.0 ± 10.2 38.0 ± 11.1
LNS 50 ± 10 48.1 ± 10.5 37.5 ± 11.2
NAB
Mazes
50.1 ± 10 47.6 ± 10.8 38.0 ± 10.2
BVMT-R 50.1 ± 10 46.6 ± 12.2 32.2 ± 14.7
Fluency 50 ± 10 47.4 ± 9.6 32.7 ± 14.6
CPT-IP 50.1 ± 10 46.7 ± 10.2 37.3 ± 11.3
MSCEIT 50 ± 10 50.1 ± 10.4 42.3 ± 11.4
Neurocog
comp
50.1 ± 9.9 45.6 ± 11.2 28.7 ± 12.1
Overall
composite
50.1 ± 9.9 46.0 ± 11.1 28.7 ± 12.0
MCCB, MATRICS Consensus Cognitive Battery; TMT, Trail Making Test-Part A; BACS-SC, Brief
Assessment of Cognition in Schizophrenia Symbol Coding; HVLT-R, Hopkins Verbal Learning
Test-Revised; WMS-III SS, Wechsler Memory Scale Spatial Span; LNS, Letter-Number Span;
NAB Mazes, Neuropsychological Assessment Battery-Mazes; BVMT-R, Brief Visuospatial
Memory Test-Revised; Fluency, Category Fluency-Animal Naming; CPT-IP, Continuous
Performance Test-Identical Pairs; MSCEIT, Mayer-Salovey-Caruso Emotional Intelligence
Test; Neurocog Comp, Neurocognitive composite.
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The effect size of the impairment in relatives found in our
study, ranging from small to medium (0.23–0.46), is comparable
with what has been reported by several other studies focusing on
neurocognitive functions (Sitskoorn et al. 2004; Szöke et al. 2005;
Snitz et al. 2006; Trandafir et al. 2006; Schulze-Rauschenbach
et al. 2015). Working memory, Speed of processing, Attention
and Spatial memory were the most impaired, while Verbal mem-
ory and Problem solving the least impaired. While there is a gen-
eral agreement on the neurocognitive domains found impaired in
relatives, the effect size for each domain was found to vary (Snitz
et al. 2006; Trandafir et al. 2006; Gur et al. 2007;
Schulze-Rauschenbach et al. 2015). Possible reasons for the
Fig. 1. Neurocognitive profile of patients with schizophrenia and their unaffected relatives on the MATRICS Consensus Cognitive Battery (MCCB). T-scores standar-
dized to the Italian normative sample (mean 50 and S.D. 10) are reported, with correction for age, gender, and education effects. All pairwise comparisons (patients
v. controls, relatives v. controls, and patients v. relatives) are statistically significant ( post hoc Tamhane test p < 0.017, controlled for multiple comparisons), except
for Social cognition, for which patients differed from controls and relatives, but the latter group did not differ from controls.
Table 2. Weighted least-square regression estimates of the association between proband and unaffected relatives scores on the MATRICS Consensus Cognitive
Battery (MCCB) individual tests and domains (separately reported only for the two domains which include more than one test) and composite scores
MCCB test (domain) Unadj. stand. β p r2 (%) Adj. stand.*β p r2 (%)
Trail Making Test (Speed of Processing) 0.169 <0.001 3.6 1.373 <0.001 1.9
BACS-Symbol Coding (Speed of Processing) 0.238 <0.001 5.2 0.199 <0.001 3.4
Category Fluency (Speed of Processing) 0.147 0.010 1.6 0.138 0.013 1.3
Hopkins Verbal Learning Test-Revised (Verbal learning) 0.267 <0.001 7.2 0.237 <0.001 5.3
Brief Visuospatial memory Test-Revised (Visual learning) 0.088 0.079 0.6 – – –
WSM-Spatial Span (Working memory) 0.219 <0.001 5.4 0.184 <0.001 3.2
Letter Number Span (Working memory) 0.093 0.055 0.8 – – –
NAB-Mazes (Reasoning and problem solving) 0.214 <0.001 3.8 0.196 <0.001 3.0
CPT-Identical Pairs (Attention/vigilance) 0.131 0.012 1.6 0.116 0.010 0.2
MSCEIT Managing Emotions (Social cognition) 0.247 <0.001 7.1 0.23 <0.001 5.8
MCCB Domains and composite scores
Speed of processing 0.247 <0.001 6.2 0.208 <0.001 4.6
Working memory 0.173 <0.001 3.2 0.159 <0.001 2.2
Neurocognitive composite 0.213 <0.001 4.3 0.187 <0.001 3.3
Overall composite 0.247 <0.001 6.1 0.224 <0.001 4.7
Adj., adjusted; Unadj., unadjusted; stand., standardized; *adjusted for relatives’ gender, age, and relationship with the proband (parent/sibling) and weighted for the number of relatives.
BACS, Brief Assessment of Cognition in Schizophrenia; WSM, Wechsler Memory Scale-Third Edition; NAB, Neuropsychological Assessment Battery; CPT, Continuous Performance Test.
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discrepancies seem to be the type of relatives included in different
studies (young sibling/offspring are generally found more
impaired than older parents), age- and education-matching
between relatives and controls (unmatched sample present the
greatest difference) and the exclusion criteria, in particular, the
exclusion of Axis II diagnoses in relatives (Snitz et al. 2006; Gur
et al. 2007; Calkins et al. 2013; Schulze-Rauschenbach et al.
2015). In our study, the relatives were mostly parents, whose
age at testing was beyond the schizophrenia maximum age risk,
without any Axis I or II diagnosis, and we compared age- and
education-corrected scores.
The only domain that did not show an impairment in relatives
in our study was Social cognition. Literature findings for this
domain have been mixed, ranging from a mild-to-moderate
impairment to no deficit (Eack et al. 2010; Fett et al. 2013;
Kohler et al. 2014; Ruocco et al. 2014; Gur & Gur, 2016). The
use of heterogeneous measures of Social cognition, the age of
included subjects, the presence of prodromal symptoms or Axis
I or II diagnoses are again the main factors involved in the hetero-
geneity of findings (Kohler et al. 2014; Gur & Gur, 2016).
Our study is the first one to investigate aggregation in families
of the MCCB scores. With the exception of Spatial memory, all
MCCB domain scores were significantly predicted by the corre-
sponding proband scores. The effect size was larger for Social cog-
nition, Verbal memory, Speed of processing (in particular for the
Symbol Coding test), Working memory, in particular the Spatial
Span, and Reasoning and problem solving (as assessed by the
Mazes test), while the Attention/vigilance domain had the least
effect size. These results are in general agreement with those
reported by Calkins et al. (2013), using the Penn Computerized
Neurocognitive Battery (CNB), except for Verbal memory,
which in their study was not found to be predicted by proband
scores. The discrepancy concerning the prediction of this domain
might be due to methodological factors or to different liability to
schizophrenia within the samples included in the two studies. As
to methodological factors, Verbal memory in Calkins et al.’s study
was assessed only for a subsample of subjects and was found to be
intact in relatives, at odds with our and other findings (Sitskoorn
et al. 2004; Szöke et al. 2005; Snitz et al. 2006; Trandafir et al.
2006; Schulze-Rauschenbach et al. 2015; Hou et al. 2016). It is
also possible that some of the relatives have less unexpressed
liability to schizophrenia and might present with less Verbal
memory impairment. Future studies could clarify whether the
pattern of impairment in relatives of patients with schizophrenia
is related to the degree of unexpressed liability to schizophrenia.
A general problem with the family study literature is the use of
many different measures of neuropsychological performance. The
use of MCCB might help to standardize the use of cognitive tests
and domains in schizophrenia family studies. Social cognition, as
assessed by the MSCEIT, was not impaired in our sample of
unaffected first-degree relatives. However, proband scores signifi-
cantly predicted relative scores, and explained 5.8% of the latter
scores variance. Apart from the Calkins et al. study, including a
simple facial emotion recognition task, to our knowledge, there
is no other study investigating familial aggregation of deficit on
this domain.
An unresolved issue is whether the observed aggregations are
specific to schizophrenia or reflect the transmission of cognitive
abilities in families. Only studies including relatives of patients
and of healthy subjects might clarify the latter issue.
In conclusion, in a large sample of stabilized patients with
schizophrenia, living in the community, and in their unaffected
relatives, MCCB demonstrated sensitivity to cognitive deficits in
both groups. Our findings of significant within-family prediction
of MCCB scores might suggest an influence of disease-related
genetic and environmental factors on several cognitive domains,
including social cognition. As recently reported in a meta-analysis
of twin and family-based heritability studies (Blokland et al.
2017), in subjects with schizophrenia cognitive dysfunctions and
liability to the disorder have partially shared genetic etiology.
However, schizophrenia has a complex, polygenic etiology
(involving many genes with small effect sizes), and it is increas-
ingly acknowledged that gene x environment interactions, epigen-
etically regulated gene expression, and environmental factors have
an essential contributing role in its liability (Braff & Tamminga,
2017).
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